The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Novel Reversal Agent Found Effective
An investigational drug called andexanet alfa that can reverse the anticoagulant effects of FXa inhibitors met all primary and secondary efficacy endpoints, researchers said in a late-breaking clinical trial report at the AHA meeting in Orlando.
Evaluating the Risk/Benefit Profile of Ticagrelor
November 10th 2015Analysis of data from the PEGASUS-TIMI 54 trial showed high rates of treatment discontinuation due to adverse events such as bleeding and dyspnea, with the highest rate occurring in the first year of treatment. Patients who stuck with treatment experienced a reduction in cardiovascular death, myocardial infarction, and stroke.
PROACT-4 Trial on Benefits of Troponin Testing for Acute Cardiovascular Disease
November 10th 2015Chest pain is one of the most common reasons that patients visit the emergency room, and the use of troponin testing can help cut down the time between first medical contact to final patient disposition.
OK to Give tPA to Stroke Patients on NOACs
Intravenous administration of tissue plasminogen activator (tPA) appears safe in selected patients who were already on novel oral anticoagulants (NOACs) a team reported at the American Heart Association Annual Scientitific Session in Orlando, FL.
CHA2DS2-VASc Scores Useful Even When Patients Do Not Have Atrial Fibrillation
The scoring system known as CHA2DS2-VASc is commonly used as a clinical guideline for assessing ischemic stroke risk in patients with atrial fibrillation (AF). A research team from Santiago, Chile found it can also predict vascular dysfunction and cardiovascular events in high-risk patients who do not have AF.
Can Telomere Length Predict Stroke Risk?
Independent of cardiac risk factors, including chronological age and blood pressure preserved telomere length "represents healthy cellular aging," Dhananjay Vaidya and colleagues at Johns Hopkins University reported in an abstract.
Testosterone Replacement OKd for Men with Heart Disease
November 9th 2015Men with documented testosterone deficiency should be allowed to take testosterone replacement therapy if they have cardiovascular disease (CVD) or localized prostate cancer, according to new guidelines issued by the Canadian Men’s Health Foundation.
No Evidence HPV Vaccine Causes CRPS or POTS in Young Women
A committee of the European Medicines Agency has completed a long-anticipated review finding no evidence that human papillomavirus (HPV) vaccines trigger complex regional pain syndrome (CRPS) or postural orthostatic tachycardia syndrome (POTS).
Q&A With Daniel Ouellette From Henry Ford Hospital: Benefits Seen In Raising Smoking Age To 21
With the federal government leaving it to state and local entities to determine the age at which tobacco products can be purchased, an effort is underway to advance the age limit three years to 21.